Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

The role of nicotinic cholinergic neurotransmission in delusional thinking
Michael Caton, Enrique L. M. Ochoa, Francisco J. Barrantes
Schizophrenia (2020) Vol. 6, Iss. 1
Open Access | Times Cited: 40

Showing 1-25 of 40 citing articles:

Medicinal Chemistry of Indane and Its Analogues: A Mini Review
Parteek Prasher, Mousmee Sharma
ChemistrySelect (2021) Vol. 6, Iss. 11, pp. 2658-2677
Closed Access | Times Cited: 59
Are the epigenetic changes predictive of therapeutic efficacy for psychiatric disorders? A translational approach towards novel drug targets
Vincenzo Micale, Martina Di Bartolomeo, Serena Di Martino, et al.
Pharmacology & Therapeutics (2022) Vol. 241, pp. 108279-108279
Closed Access | Times Cited: 30
Nicotinic Acetylcholine Receptor Dysfunction in Addiction and in Some Neurodegenerative and Neuropsychiatric Diseases
Ana Sofía Vallés, Francisco J. Barrantes
Cells (2023) Vol. 12, Iss. 16, pp. 2051-2051
Open Access | Times Cited: 19
Tremendous Fidelity of Vitamin D3 in Age-related Neurological Disorders
Manjari Skv, Sharon Mariam Abraham, Omalur Eshwari, et al.
Molecular Neurobiology (2024) Vol. 61, Iss. 9, pp. 7211-7238
Closed Access | Times Cited: 6
The New Horizon of Antipsychotics beyond the Classic Dopaminergic Hypothesis—The Case of the Xanomeline–Trospium Combination: A Systematic Review
Octavian Vasiliu, Beatrice Budeanu, Mihai-Ștefan Cătănescu
Pharmaceuticals (2024) Vol. 17, Iss. 5, pp. 610-610
Open Access | Times Cited: 6
Homomeric and Heteromeric α7 Nicotinic Acetylcholine Receptors in Health and Some Central Nervous System Diseases
Virginia Borroni, Francisco J. Barrantes
Membranes (2021) Vol. 11, Iss. 9, pp. 664-664
Open Access | Times Cited: 29
Epigenetic Control in Schizophrenia
Claudio D’Addario, Martina Di Bartolomeo
Sub-cellular biochemistry/Subcellular biochemistry (2025), pp. 191-215
Closed Access
Does KarXT (xanomeline-trospium) represent a novel approach to schizophrenia management? A GRADE-assessed systematic review and meta-analysis of randomized controlled clinical trials
Hazem Mohammed, M. Gomaa, Y. Khalifa, et al.
BMC Psychiatry (2025) Vol. 25, Iss. 1
Open Access
Clinical and Structural Differences in Delusions Across Diagnoses: A Systematic Review
Kelly Rootes-Murdy, David R. Goldsmith, Jessica A. Turner
Frontiers in Integrative Neuroscience (2022) Vol. 15
Open Access | Times Cited: 15
Increased Metabolic Potential, Efficacy, and Safety of Emerging Treatments in Schizophrenia
Jonathan M. Meyer, Christoph U. Correll
CNS Drugs (2023) Vol. 37, Iss. 7, pp. 545-570
Open Access | Times Cited: 7
Characterization of Binding Site Interactions and Selectivity Principles in the α3β4 Nicotinic Acetylcholine Receptor
Hailey J. Knox, Hugo Rego Campello, Henry A. Lester, et al.
Journal of the American Chemical Society (2022) Vol. 144, Iss. 35, pp. 16101-16117
Closed Access | Times Cited: 12
Delusion and Delirium in Neurodegenerative Disorders: An Overlooked Relationship?
Daniele Urso, Valentina Gnoni, Marco Filardi, et al.
Frontiers in Psychiatry (2022) Vol. 12
Open Access | Times Cited: 10
Molecular Mingling: Multimodal Predictions of Ligand Promiscuity in Pentameric Ligand-Gated Ion Channels
Filip Koniuszewski, Florian Vogel, Konstantina Bampali, et al.
Frontiers in Molecular Biosciences (2022) Vol. 9
Open Access | Times Cited: 10
Cholinergic Antagonists and Behavioral Disturbances in Neurodegenerative Diseases
Rachid Mahmoudi, Jean‐Luc Novella, Sarah Laurent-Badr, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 8, pp. 6921-6921
Open Access | Times Cited: 6
Clinical and Immunological Aspects of Delusional Disorders in Paranoid Schizophrenia
T. P. Klyushnik, Smulevich Ab, S. A. Zozulya, et al.
Psikhiatriya (2023) Vol. 21, Iss. 2, pp. 6-16
Open Access | Times Cited: 5
Unprecedented effect of vitamin D3 on T-cell receptor beta subunit and alpha7 nicotinic acetylcholine receptor expression in a 3-nitropropionic acid induced mouse model of Huntington’s disease
S.K.V. Manjari, Sharon Mariam Abraham, R. Poornima, et al.
IBRO Neuroscience Reports (2023) Vol. 15, pp. 116-125
Open Access | Times Cited: 5
Disorganization of Oscillatory Activity in Animal Models of Schizophrenia
Lucinda J. Speers, David K. Bilkey
Frontiers in Neural Circuits (2021) Vol. 15
Open Access | Times Cited: 12
Morphological and biochemical repercussions of Toxoplasma gondii infection in a 3D human brain neurospheres model
Paulo Emílio Corrêa Leite, Juliana de Araújo Portes, Mariana Rodrigues Pereira, et al.
Brain Behavior & Immunity - Health (2020) Vol. 11, pp. 100190-100190
Open Access | Times Cited: 12
Neuronal Menin Overexpression Rescues Learning and Memory Phenotype in CA1-Specific α7 nAChRs KD Mice
Shadab Batool, Basma Akhter, Jawwad Zaidi, et al.
Cells (2021) Vol. 10, Iss. 12, pp. 3286-3286
Open Access | Times Cited: 11
Microstructural imaging and transcriptomics of the basal forebrain in first-episode psychosis
Min Tae M Park, Peter Jeon, Leon French, et al.
Translational Psychiatry (2022) Vol. 12, Iss. 1
Open Access | Times Cited: 8
Cross-ancestry genetic investigation of schizophrenia, cannabis use disorder, and tobacco smoking
Emma C. Johnson, Isabelle Austin-Zimmerman, Hayley HA Thorpe, et al.
medRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access | Times Cited: 1
Genetic Implication of Prenatal GABAergic and Cholinergic Neuron Development in Susceptibility to Schizophrenia
Darren Cameron, Ngoc‐Nga Vinh, Parinda Prapaiwongs, et al.
Schizophrenia Bulletin (2024) Vol. 50, Iss. 5, pp. 1171-1184
Open Access | Times Cited: 1
Psychosis in Parkinson’s Disease and Current Management Trends- an Updated Review of Literature
Rajib Dutta
Journal of Neuroscience and Neurological Disorders (2023) Vol. 7, Iss. 2, pp. 027-057
Open Access | Times Cited: 2
Basal-Forebrain Cholinergic Nuclei Alterations are Associated With Medication and Cognitive Deficits Across the Schizophrenia Spectrum
Julia Schulz, Felix Brandl, Michel J. Grothe, et al.
Schizophrenia Bulletin (2023) Vol. 49, Iss. 6, pp. 1530-1541
Open Access | Times Cited: 2
Target enzymes in oxaliplatin-induced peripheral neuropathy in Swiss mice: A new acetylcholinesterase inhibitor as therapeutic strategy
Ketlyn P. da Motta, Beatriz F. dos Santos, Nelson Luís de Campos Domingues, et al.
Chemico-Biological Interactions (2021) Vol. 352, pp. 109772-109772
Open Access | Times Cited: 4
Page 1 - Next Page

Scroll to top